April 11, 2016 By Reuters
ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To establish a wholly owned subsidiary in the United States, namely VcanBio Center for Translational Biotechnology Corp.The new subsidiary with a registered capital of $5 mln. Read full article from Reuters
